Phase II study of decitabine in acute myeloid leukemia
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 18 May 2016 Time frame for primary endpoint has been changed.
- 18 May 2016 Status changed from active, no longer recruiting to completed.
- 12 Aug 2015 The recruitment status of this study is unknown because the information has not been verified recently (Verified on February 2013 ). So kept previous status as active not recruiting as per ClinicalTrials.gov record.